Loading…
Vipul Organics (BSE 530627)₹220.10−0.41%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Vipul Organics reported sales of ₹51.99 Cr, up 37.9% from Jun 2025, and net profit of ₹2.52 Cr, up 96.9% year on year. For the year to Mar 2026, sales were ₹176 Cr and net profit ₹6.99 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 36.67 | 37.56 | 40.15 | 38.18 | 39.36 | 41.54 | 44.26 | 37.71 | 39.58 | 46.31 | 52.38 | 51.99 |
| Expenses | 33.57 | 34.29 | 36.75 | 34.73 | 35.48 | 37.45 | 40.25 | 33.76 | 35.03 | 41.68 | 47.35 | 46.70 |
| Operating Profit | 2.87 | 3.06 | 3.14 | 3.26 | 3.66 | 3.87 | 3.73 | 3.77 | 4.31 | 4.34 | 4.77 | 4.98 |
| OPM % | 7.9% | 8.2% | 7.9% | 8.6% | 9.4% | 9.4% | 8.5% | 10.1% | 11.0% | 9.5% | 9.2% | 9.7% |
| Other Income | 0.06 | 0.18 | 0.54 | 0.13 | 0.18 | 0.11 | −0.10 | 0.08 | 0.22 | 0.23 | 0.39 | 0.39 |
| Interest | 0.54 | 0.57 | 0.66 | 0.59 | 0.65 | 0.60 | 0.88 | 0.71 | 0.55 | 0.50 | 0.55 | 0.54 |
| Depreciation | 1.37 | 1.40 | 1.51 | 1.25 | 1.46 | 1.60 | 1.61 | 1.56 | 1.63 | 1.59 | 1.64 | 1.42 |
| Profit before tax | 1.07 | 1.32 | 1.56 | 1.60 | 1.78 | 1.83 | 1.17 | 1.63 | 2.40 | 2.53 | 3.02 | 3.46 |
| Tax % | 7.5% | 38.9% | 30.9% | 28.3% | 39.5% | 20.8% | 32.7% | 21.5% | 24.2% | 26.5% | 34.2% | 26.7% |
| Net Profit | 1.01 | 0.81 | 1.08 | 1.13 | 1.05 | 1.44 | 0.77 | 1.28 | 1.82 | 1.84 | 1.97 | 2.52 |
| EPS (Rs) | 0.57 | 0.46 | 0.61 | 0.65 | 0.60 | 0.81 | 0.44 | 0.71 | 1.01 | 0.96 | 1.03 | 1.32 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 53.20 | 57.24 | 79.28 | 90.33 | 92.25 | 119 | 134 | 134 | 151 | 164 | 176 | 190 |
| Expenses | 49.91 | 53.89 | 74.91 | 83.84 | 82.90 | 103 | 117 | 122 | 138 | 148 | 158 | 171 |
| Operating Profit | 2.99 | 2.99 | 3.99 | 5.99 | 8.98 | 15.98 | 15.97 | 11.97 | 11.97 | 13.96 | 16.97 | 18.40 |
| OPM % | 5.0% | 6.0% | 5.0% | 7.0% | 10.0% | 14.0% | 12.0% | 9.0% | 8.0% | 9.0% | 10.1% | 9.7% |
| Other Income | 0.00 | 0.99 | 0.99 | 0.00 | 0.99 | 0.99 | 0.99 | 0.00 | 0.99 | 0.00 | 0.99 | 1.23 |
| Interest | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 3.01 | 2.01 | 3.01 | 2.01 | 2.14 |
| Depreciation | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 6.01 | 5.02 | 6.02 | 6.02 | 6.02 | 6.01 | 6.28 |
| Profit before tax | 1.01 | 2.01 | 3.01 | 5.01 | 7.02 | 10.04 | 10.03 | 3.01 | 5.02 | 6.01 | 10.04 | 11.41 |
| Tax % | 32.9% | 31.9% | 33.9% | 30.0% | 32.0% | 27.9% | 28.0% | 31.9% | 28.0% | 30.0% | 27.9% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 1.01 | 1.99 | 2.01 | 4.01 | 5.01 | 6.99 | 6.99 | 2.01 | 3.01 | 3.99 | 6.99 | 8.15 |
| EPS (Rs) | 0.99 | 1.53 | 1.73 | 2.73 | 3.70 | 4.30 | 4.07 | 1.08 | 1.92 | 2.49 | 3.62 | 4.32 |
| Dividend payout % | 48.0% | 31.0% | 28.0% | 18.0% | 13.0% | 13.0% | 13.0% | 62.0% | 39.0% | 24.0% | 22.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.99 | 4.98 | 5.99 | 7.98 | 7.97 | 7.97 | 9.97 | 9.96 | 12.95 | 12.95 | 12.95 | 18.92 |
| Reserves | 6.99 | 7.99 | 13.02 | 18.02 | 20.02 | 25.02 | 29.03 | 42.01 | 40.03 | 45.01 | 50.99 | 98.09 |
| Borrowings | 9.98 | 6.99 | 9.99 | 18.97 | 18.96 | 21.95 | 29.93 | 29.95 | 30.95 | 29.94 | 45.89 | 52.93 |
| Other Liabilities | 14.00 | 13.02 | 15.97 | 25.94 | 25.93 | 42.11 | 39.04 | 44.02 | 40.04 | 48.09 | 45.04 | 60.85 |
| Total Liabilities | 36.96 | 32.98 | 45.97 | 69.91 | 72.88 | 96.05 | 107 | 127 | 124 | 136 | 155 | 231 |
| Fixed Assets | 6.01 | 6.02 | 6.02 | 6.02 | 6.02 | 32.09 | 29.07 | 36.11 | 35.10 | 32.09 | 38.09 | 37.08 |
| CWIP | 0.00 | 0.00 | 0.99 | 4.98 | 16.95 | 0.00 | 0.00 | 0.00 | 0.00 | 4.98 | 8.97 | 38.86 |
| Investments | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.99 | 0.00 | 0.00 |
| Other Assets | 29.95 | 26.96 | 37.97 | 57.92 | 49.92 | 62.97 | 76.91 | 89.84 | 87.87 | 97.93 | 107 | 154 |
| Inventories | 6.02 | 5.02 | 8.03 | 9.04 | 9.04 | 17.06 | 18.07 | 31.10 | 35.13 | 33.11 | 36.11 | 46.20 |
| Trade receivables | 12.04 | 10.04 | 15.05 | 29.13 | 21.09 | 25.08 | 35.14 | 43.19 | 34.13 | 44.18 | 51.20 | 54.20 |
| Cash & equivalents | 2.01 | 2.01 | 5.01 | 3.01 | 3.01 | 5.01 | 6.01 | 3.01 | 6.02 | 2.01 | 2.01 | 30.07 |
| Total Assets | 36.96 | 32.98 | 45.97 | 69.91 | 72.88 | 96.05 | 107 | 127 | 124 | 136 | 155 | 231 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 3.01 | 5.01 | −4.01 | −8.01 | 15.01 | 14.01 | −2.01 | 2.01 | 10.01 | 5.01 | 1.01 | 11.01 |
| Cash from investing activity | −1.99 | 0.00 | −1.99 | −3.99 | −10.95 | −10.95 | −1.99 | −10.96 | −2.99 | −6.97 | −14.94 | −33.87 |
| Cash from financing activity | −0.99 | −3.99 | 6.98 | 10.98 | −1.99 | 0.00 | 3.99 | 4.99 | −4.99 | −1.99 | 14.97 | 24.96 |
| Net cash flow | 0.00 | 0.00 | 0.99 | −1.99 | 0.99 | 2.99 | 0.99 | −2.99 | 2.99 | −3.99 | 0.00 | 0.99 |
| Capex | 2.25 | 0.45 | 2.57 | 4.76 | 11.73 | 11.28 | 1.50 | 13.51 | 3.12 | 6.98 | 15.93 | 35.06 |
| Free cash flow | 1.01 | 4.01 | −7.02 | −13.03 | 3.01 | 3.01 | −4.01 | −10.03 | 7.02 | −2.01 | −15.05 | −24.06 |
| CFO / OP % | 144.1% | 172.0% | −99.9% | −183.0% | 255.0% | 180.1% | −3.0% | 34.0% | 104.1% | 53.0% | 18.0% | 76.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 84 | 73 | 96 | 133 | 85 | 100 | 110 | 118 | 94 | 109 | 115 | 114 |
| Inventory days | 54 | 50 | 69 | 54 | 49 | 96 | 87 | 131 | 150 | 122 | 127 | 146 |
| Days payable | 113 | 110 | 135 | 143 | 116 | 210 | 161 | 166 | 142 | 147 | 127 | 153 |
| Cash conversion cycle | 24 | 12 | 28 | 43 | 17 | −15 | 35 | 81 | 101 | 83 | 114 | 105 |
| Working capital days | −8 | −5 | 6 | 18 | 16 | −8 | 34 | 45 | 45 | 42 | 37 | 36 |
| ROCE % | 8.0% | 10.1% | 12.0% | 12.0% | 13.1% | 16.0% | 18.1% | 14.0% | 7.0% | 8.0% | 9.0% | 8.0% |
For the Jun 2026 quarter, Vipul Organics reported sales of ₹51.99 Cr, up 37.9% year on year and net profit of ₹2.52 Cr, up 96.9% year on year. The operating margin was 9.7%.
Vipul Organics' sales for the year to Mar 2026 were ₹176 Cr; over the last twelve months they were ₹190 Cr.
Net profit for the year to Mar 2026 was ₹6.99 Cr, and ₹8.15 Cr over the last twelve months. Earnings per share over the same trailing period were ₹4.32.
Vipul Organics reported borrowings of ₹52.93 Cr at Mar 2026, against cash and equivalents of ₹30.07 Cr.
Cash from operations was ₹11.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹24.06 Cr.